These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21829070)

  • 41. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
    Atagi S; Kawahara M; Hosoe S; Ogawara M; Kawaguchi T; Okishio K; Naka N; Sunami T; Mitsuoka S; Akira M
    Lung Cancer; 2002 Apr; 36(1):105-11. PubMed ID: 11891041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
    Nakamura M; Koizumi T; Hayasaka M; Yasuo M; Tsushima K; Kubo K; Gomi K; Shikama N
    Cancer Chemother Pharmacol; 2009 May; 63(6):1091-6. PubMed ID: 18818921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).
    Vergnenègre A; Daniel C; Léna H; Fournel P; Kleisbauer JP; Le Caer H; Letreut J; Paillotin D; Pérol M; Bouchaert E; Preux PM; Robinet G;
    Lung Cancer; 2005 Mar; 47(3):395-404. PubMed ID: 15713523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.
    Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F
    Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M;
    J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
    Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M
    Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.
    Winterhalder R; Deschler-Marini S; Landmann C; Kann R; Passweg J; Herrmann R; Pless M
    Radiother Oncol; 2004 Dec; 73(3):321-4. PubMed ID: 15588877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
    Martoni AA; Melotti B; Sperandi F; Giaquinta S; Piana E; Pavesi L; Da Prada G; Lelli G
    Lung Cancer; 2008 Jun; 60(3):387-92. PubMed ID: 18160123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
    Tan EH; Wee J; Ang PT; Fong KW; Leong SS; Khoo KS; Tan T; Lee KS; Eng P; Hsu A; Tan YK; Chua EJ; Ong YY
    Acta Oncol; 1999; 38(8):1005-9. PubMed ID: 10665753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.
    Sekine I; Noda K; Oshita F; Yamada K; Tanaka M; Yamashita K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Sumi M; Saijo N
    Cancer Sci; 2004 Aug; 95(8):691-5. PubMed ID: 15298734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
    Hazuka MB; Crowley JJ; Bunn PA; O'Rourke M; Braun TJ; Livingston RB
    J Clin Oncol; 1994 Sep; 12(9):1814-20. PubMed ID: 8083705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
    Furuse K; Kubota K; Kawahara M; Kodama N; Ogawara M; Akira M; Nakajima S; Takada M; Kusunoki Y; Negoro S
    J Clin Oncol; 1995 Apr; 13(4):869-75. PubMed ID: 7707113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.
    Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N
    Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
    Hoffman PC; Cohen EE; Masters GA; Haraf DJ; Mauer AM; Rudin CM; Krauss SA; Huo D; Vokes EE
    Lung Cancer; 2002 Oct; 38(1):65-71. PubMed ID: 12367795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combination of cisplatin and vinorelbine as adjuvant chemotherapy in non-small cell lung cancer patients--feasibility assessment of 5 consecutively treated patients].
    Hirahara K; Tanaka J; Itoh R; Kuriyama H; Tanaka H; Kagamu H; Yoshizawa H; Gejyo F
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):109-11. PubMed ID: 18195537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC).
    Tsoutsou PG; Froudarakis ME; Bouros D; Koukourakis MI
    Anticancer Res; 2008; 28(2B):1349-54. PubMed ID: 18505077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.
    Kawaguchi T; Takada M; Ando M; Okishio K; Atagi S; Fujita Y; Tomizawa Y; Hayashihara K; Okano Y; Takahashi F; Saito R; Matsumura A; Tamura A
    Eur J Cancer; 2012 Mar; 48(5):672-7. PubMed ID: 22172569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.